# Clinical Study of GH001 in Depression

> **NCT04698603** · PHASE1,PHASE2 · COMPLETED · sponsor: **GH Research Ireland Limited** · enrollment: 16 (actual)

## Conditions studied

- Treatment Resistant Depression
- Major Depressive Disorder
- Depression

## Interventions

- **DRUG:** 5 Methoxy N,N Dimethyltryptamine

## Key facts

- **NCT ID:** NCT04698603
- **Lead sponsor:** GH Research Ireland Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2021-11-06
- **Final completion:** 2021-11-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698603, "Clinical Study of GH001 in Depression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04698603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*